UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 103 filers reported holding UROGEN PHARMA LTD in Q3 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,943,440 | +35.4% | 495,606 | 0.0% | 2.79% | +42.9% |
| Q2 2023 | $5,129,522 | +12.0% | 495,606 | 0.0% | 1.95% | +14.7% |
| Q1 2023 | $4,579,399 | -3.2% | 495,606 | -7.0% | 1.70% | -5.7% |
| Q4 2022 | $4,728,943 | +6.6% | 533,139 | 0.0% | 1.80% | +5.9% |
| Q3 2022 | $4,436,000 | +1.6% | 533,139 | 0.0% | 1.70% | +17.9% |
| Q2 2022 | $4,366,000 | -6.0% | 533,139 | 0.0% | 1.45% | +21.7% |
| Q1 2022 | $4,644,000 | -8.4% | 533,139 | 0.0% | 1.19% | +43.8% |
| Q4 2021 | $5,070,000 | -43.5% | 533,139 | 0.0% | 0.83% | -28.9% |
| Q3 2021 | $8,967,000 | +10.1% | 533,139 | 0.0% | 1.16% | +25.6% |
| Q2 2021 | $8,141,000 | -21.6% | 533,139 | 0.0% | 0.92% | -27.1% |
| Q1 2021 | $10,386,000 | -54.0% | 533,139 | -57.4% | 1.27% | -55.3% |
| Q4 2020 | $22,566,000 | -6.6% | 1,252,285 | 0.0% | 2.84% | -63.3% |
| Q3 2020 | $24,156,000 | +2.7% | 1,252,285 | +39.1% | 7.72% | -4.9% |
| Q2 2020 | $23,512,000 | +46.4% | 900,148 | 0.0% | 8.12% | +11.1% |
| Q1 2020 | $16,058,000 | -58.4% | 900,148 | -22.1% | 7.31% | -34.3% |
| Q4 2019 | $38,571,000 | +53.3% | 1,155,862 | +9.5% | 11.13% | +4.1% |
| Q3 2019 | $25,166,000 | -17.0% | 1,056,062 | +25.2% | 10.69% | -18.5% |
| Q2 2019 | $30,311,000 | +5.3% | 843,365 | +8.3% | 13.12% | -22.2% |
| Q1 2019 | $28,776,000 | +9.1% | 779,003 | +27.2% | 16.86% | -2.7% |
| Q4 2018 | $26,374,000 | +48.7% | 612,494 | +63.1% | 17.34% | +26.7% |
| Q3 2018 | $17,734,000 | +41.7% | 375,479 | +49.3% | 13.68% | +42.9% |
| Q2 2018 | $12,513,000 | +38.6% | 251,459 | +38.4% | 9.57% | +28.5% |
| Q1 2018 | $9,029,000 | +90.6% | 181,702 | +42.7% | 7.45% | +47.7% |
| Q4 2017 | $4,738,000 | +11.4% | 127,313 | -5.7% | 5.04% | +560.7% |
| Q3 2017 | $4,255,000 | +74.5% | 135,000 | 0.0% | 0.76% | +17.7% |
| Q2 2017 | $2,439,000 | – | 135,000 | – | 0.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,620,545 | $36,713,835 | 6.69% |
| Wildcat Capital Management, LLC | 495,606 | $6,943,440 | 2.79% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 508,883 | $7,129,451 | 2.16% |
| Opaleye Management Inc. | 320,000 | $4,483,200 | 1.46% |
| AlphaCentric Advisors LLC | 165,000 | $2,311,650 | 1.31% |
| Soleus Capital Management, L.P. | 372,000 | $5,211,720 | 0.48% |
| EAM Investors, LLC | 170,523 | $2,389,027 | 0.46% |
| RA Capital Management | 1,483,697 | $20,786,595 | 0.41% |
| Parkman Healthcare Partners LLC | 145,311 | $2,035,807 | 0.37% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,303,031 | $32,265,464 | 0.29% |